from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3105c/prfB

LFCtreatmentdescriptionclass of inhibitor

-0.123

Amikacinug/mL Amikacintranslation

0.924

Cap5-10ug/mL Capreomycintranslation

0.570

Rox10-50 ug/mL Roxithromycintranslation

1.123

SM2-5 ug/mL Streptomycintranslation

-0.922

Tet5-10 ug/mL Tetracyclinetranslation

-1.036

Rif0.2-5ug/mL Rifampicintranscription

0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.937

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.655

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.406

CPZ10-50 ug/mL Chlorpromazinerespiration

0.367

Clofazimine10-13 ug/mL Clofaziminerespiration

0.818

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.827

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.179

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.593

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.483

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.153

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.127

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.181

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.105

KCN5-20 ug/mL Potassium cyaniderespiration

1.706

NaN30.2-2 mM Sodium aziderespiration

-1.261

Nigericin50 uM Nigericinrespiration

0.213

TRC10-150 ug/mL Triclosanrespiration

0.363

TRZ10-25 ug/mL Thioridazinerespiration

-1.626

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.294

menadione6-10 ug/mL Menadionerespiration

0.272

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.522

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.062

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.994

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.346

NRP_1Non-replicating persistence stage 1dosRassociated

0.219

Amp0.2mg/mL AmpicillincellWall

-0.286

Cephalexin20-100 ug/mL CephalexincellWall

0.382

Cerulenin0.32-5 ug/mL CerulenincellWall

0.164

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.271

EMB10-20 ug/mL EthambutolcellWall

0.823

Eta12-40 ug/mL EthionamidecellWall

0.971

INH0.2-0.4 ug/mL IsoniazidcellWall

0.707

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.176

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.148

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.370

BZA0.12 mg/mL BenzamidearomaticAmides

-0.293

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.063

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.198

H2O24 mM hydrogen peroxideDNAdamaging

0.137

Levo10 ug/mL LevofloxacinDNAdamaging

-0.282

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.176

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.795

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.152

UVUV-irradiationDNAdamaging

-1.616

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.387

Antimycin12.5-50 ug/mL Antimycin A?

-1.755

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.170

PA_110-50 ug/mL Antitubercular compound PA-1?

0.453

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.338

PA8240.2-2 ug/mL PA-824?

0.141

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.683

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.883

Verapamil50 uM Verapamil?

-1.316

mercaptoethanol2 mM 2-Mercaptoethanol?

0.149

methoxatin10-20 ug/mL Methoxatin?